Navin Govind is the Founder and CEO of Aventyn, a digital therapeutics company focused on delivering clinically validated platform solutions for improving cardio renal metabolic health. Navin is a serial entrepreneur; investor, venture partner at Evidence Ventures, startup advisor, author of several original papers in peer reviewed journals, holds multiple patents and serves as speaker, faculty and advisory boards on digital health innovation. Navin has worked at the intersection of technology, medical device and software platforms for evidencing best in class clinical solutions working with clinician leaders, providers, femtech innovators and global clients. As co-founder of Kanasu Labs, Navin leads strategic health data collaboration initiatives to bring science based; advanced AI enabled deep learning solutions to lower the burden of chronic disease, cost of care, and better health outcomes. Navin is deeply committed to helping shape science based digital health standards, equitable and sustainable policy initiatives for affordable access to quality care. Navin serves as an advisor on the American Heart Association Center for Health Technology and Innovation Business Team.